Lee Min Ji, Jiang Jian, Kim Soo Hyun, Jo Chris Hyunchul
Department of Orthopedic Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Dongjak-gu, Seoul 07061, Korea.
Department of Translational Medicine, Seoul National University College of Medicine, Jongno-gu, Seoul 03080, Korea.
Stem Cells Transl Med. 2024 Dec 16;13(12):1213-1227. doi: 10.1093/stcltm/szae075.
In the treatment of cartilage defects, a key factor is the adequate and specific recruitment of endogenous stem cells to the site of injury. However, the limited quantity and capability of endogenous bone marrow stem cells (BM MSCs) often result in the formation of fibrocartilage when using bone marrow stimulation (BMS) procedures. We engineered second-generation platelet-rich plasma (2G PRP) with defibrinogenating and antifibrinolytic agents for injection into the condyle of the right femur, followed by multiple channeling (MCh) 5 days later. This approach aims to enhance repair by promoting the local proliferation and migration of BM MSCs to the full-thickness knee cartilage defect (ftKD). In our in vitro study, 2G PRP increased the number of endogenous BM MSCs and their ability to migrate toward an IL-1β-induced inflammatory condition. This significance was further confirmed by in vivo proliferation results after injection of 2G PRP into the condyle of rats. Fifty-four healthy male Sprague-Dawley rats were divided into 3 groups (ftKD, MCh, 2G MCh) for 3 time points (2 weeks, 4 weeks, 8 weeks). The 2G MCh (2G PRP injection + MCh) groups significantly improved cartilage formation at 4 and 8 weeks compared to the ftKD and MCh groups. The 2G MCh initiated cartilage repair earlier than MCh and significantly enhanced up to 8 weeks. This study demonstrated that 2G PRP increased the number of BM MSCs through the enhancement of proliferation and recruitment into the injured site, thereby improving articular cartilage repair.
在软骨缺损的治疗中,一个关键因素是将内源性干细胞充分且特异性地募集到损伤部位。然而,内源性骨髓间充质干细胞(BM MSCs)的数量和能力有限,在使用骨髓刺激(BMS)程序时,常常导致纤维软骨的形成。我们用去纤维蛋白和抗纤维蛋白溶解剂设计了第二代富血小板血浆(2G PRP),将其注射到右股骨髁,5天后进行多通道钻孔(MCh)。这种方法旨在通过促进BM MSCs向全层膝关节软骨缺损(ftKD)局部增殖和迁移来增强修复。在我们的体外研究中,2G PRP增加了内源性BM MSCs的数量及其向白细胞介素-1β诱导的炎症环境迁移的能力。将2G PRP注射到大鼠髁后,体内增殖结果进一步证实了这一意义。54只健康雄性Sprague-Dawley大鼠分为3组(ftKD、MCh、2G MCh),设置3个时间点(2周、4周、8周)。与ftKD组和MCh组相比,2G MCh(2G PRP注射+MCh)组在4周和8周时软骨形成显著改善。2G MCh比MCh更早启动软骨修复,且在8周时显著增强。本研究表明,2G PRP通过增强增殖和募集到损伤部位来增加BM MSCs的数量,从而改善关节软骨修复。